In this study, we found evidence that RalA GTPase activity is significantly increased in CML cell lines and primary CML cells from patients compared to normal blood control (Figure 1A), without altering RalA expression in mRNA and protein levels (Figure S1). This evidence concerns the gene RALA and chronic myelogenous leukemia, BCR-ABL1 positive.